PROCEPT BIOROBOTICS CORP

PROCEPT BioRobotics’ autonomous tissue removal tech redefines BPH surgery, boosting precision, safety, and recovery while driving global growth.

PROCEPT BioRobotics Corp: 2026 stock outlook and financial challenges – a deep dive into its market volatility, negative earnings, and future prospects for investors.

PROCEPT BioRobotics Corp has reported strong revenue growth, with a 48% year-over-year increase in Q2 2025, despite facing challenges such as delayed system replacements and a leadership transition.